Clinical trial · Observational

Thyroid Cancer in United Arab Emirates

Decline in Radioiodine Use But Not Total Thyroidectomy in Thyroid Cancer Patients Treated in United Arab Emirates- A Retrospective Study

NCT04763122CI-TRIAL-00050218completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

The main objective of the study is to assess the trend of clinicopathological features and treatment modalities in patients with thyroid cancer in the largest oncology center in the United Arab Emirates (UAE).

Conditions

Conditions (2)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Cancer	Malignant Neoplasm	ALIAS	0.90
Thyroid	—	UNRESOLVED	—

Interventions

Interventions (1)

Intervention	Type	Mapped drug	Match
not applicable as it is a retrospective study	Other	—	UNRESOLVED

Design

Arms and outcomes

Arms (1)

label
Thyroid Cancer Cases
interventionNames
1. Other: not applicable as it is a retrospective study

Primary outcomes (3)

measure
Clinicopathological features
timeFrame
September 2008- December 2018
description
Assess clinicopathological features of thyroid cancer patients
measure
Extent of surgery
timeFrame
September 2008- December 2018
description
Assess extent of surgery in thyroid cancer patients and changes over time
measure
Use of RAI
timeFrame

Eligibility

Eligibility (as posted)

Sex: All

Show eligibility criteria text

Inclusion Criteria:

* All patients with Thyroid Cancer presenting to Tawam Hospital during the period of September 2008 and December 2018.

Exclusion Criteria:

* Patients with inadequate data, noninvasive follicular type PTC and incorrect pathological diagnosis,

References

Publications (0)

Data not yet available

No reference posted for this study.